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Abstract: Brevibacillus laterosporus, a bacterium characterized by the production of a 
unique canoe-shaped lamellar body attached to one side of the spore, is a natural inhabitant 
of water, soil and insects. Its biopesticidal potential has been reported against insects in 
different orders including Coleoptera, Lepidoptera, Diptera and against nematodes and 
mollusks. In addition to its pathogenicity against invertebrates, different B. laterosporus 
strains show a broad-spectrum antimicrobial activity including activity against 
phytopathogenic bacteria and fungi. A wide variety of molecules, including proteins and 
antibiotics, have been associated with the observed pathogenicity and mode of action. 
Before being considered as a biological control agent against plant pathogens, the 
antifungal and antibacterial properties of certain B. laterosporus strains have found medical 
interest, associated with the production of antibiotics with therapeutic effects. The recent 
whole genome sequencing of this species revealed its potential to produce polyketides, 
nonribosomal peptides, and toxins. Another field of growing interest is the use of this 
bacterium for bioremediation of contaminated sites by exploiting its biodegradation 
properties. The aim of the present review is to gather and discuss all recent findings on this 
emerging entomopathogen, giving a wider picture of its complex and broad-spectrum 
biocontrol activity. 
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Brevibacillus laterosporus Laubach is a rod-shaped, endospore-forming bacterium morphologically 
characterized by the production of a typical canoe-shaped parasporal body (CSPB) firmly attached to 
one side of the spore, which determines its lateral position in the sporangium (Figure 1).  
It is an ubiquitous species that has been isolated from a wide range of materials including soil [1], 
gemstones [2], lahar [3], fresh water [4], sea water [5], insect bodies [6], leaf surfaces [7], locust beans [8]; 
compost [9], milk [10], cheese [11], honey [12], starchy foods [13], gelatin-factory effluents [14], 
animal hide and wool [15], quails [16]. 
The significance of its relationships with insects was noted after it was first isolated at the beginning 
of the 20th century by White (1912) who was conducting studies on the bacterial community of 
honeybees affected by European foulbrood. Among secondary invaders in the disease, he isolated a 
new species that he named Bacillus orpheus White [6]. A detailed description of the bacterium was 
given in 1917 by McCray, who isolated different spore-forming bacteria of an apiary [17]. However, a 
year earlier, Bacillus laterosporus had been named and described by Laubach, who isolated a different 
strain from fresh water [4]. Later on, given the correspondence between the two isolates, the second 
name had priority and was chosen to designate this bacterium [18]. In 1946 Steinhaus listed it among 
spore-forming entomogenous species [19]. As a result of recent taxonomic studies based on 16S rRNA 
sequence analysis, this species has been relocated in the new genus Brevibacillus within the 
Brevibacillus brevis cluster [20].  
The biocontrol potential of this entomopathogenic species has been reported against insects in 
different orders including Coleoptera, Lepidoptera, Diptera and against nematodes and mollusks [21]. 
Non-pathogenic effects towards non-target species have also been noted for entomopathogenic strains. 
B. laterosporus is also an occasional inhabitant of honeybee bodies. It has been isolated from the 
digestive tract of healthy foraging adult workers, although its occurrence was sporadic in the examined 
samples [22]. Occasionally, it has been isolated from diseased honeybee larvae, especially those 
affected by European foulbrood (EFB). However, it has been considered to be a probiotic or just a 
secondary bacterial invader [23,24]. It is listed among bacteria that do not cause European foulbrood, 
but can be helpful in its diagnosis because it influences the odor and consistency of the dead brood, 
together with Paenibacillus alvei Cheshire and Cheyne, Enterococcus faecalis (Andrewes and Horder) 
Schleifer and Kilpper-Balz, Bacterium eurydice White and Paenibacillus apiarius (Katznelson) 
Nakamura [25]. 
In addition to its pathogenicity against invertebrates, different strains of B. laterosporus show a 
broad-spectrum antimicrobial activity especially against bacteria and fungi. A wide variety of 
molecules, including proteins and antibiotics, have been associated with the observed pathogenicity 
and mode of action. A recent whole genome sequencing of this species revealed its potential to 
produce polyketides, nonribosomal peptides, and toxins [26,27]. This species is also listed among 
probiotics for mammals and birds [28,29], and specific antibiotics derived from it have found use in 
medicine [30]. 
The aim of the present review is to gather and discuss all recent findings on this entomopathogenic, 
nematicidal, molluscicidal and antimicrobial species, giving a wider picture of its complex and 
broad-spectrum biocontrol actions. 




Figure 1. Brevibacillus laterosporus sporangium. SW, sporangium wall; Sp, spore;  
SC, spore coat; CSPB, canoe-shaped parasporal body. 
 
2. The Canoe-Shaped Parasporal Body (CSPB) and Other Parasporal Bodies (PBs) 
The main morphological feature characterizing B. laterosporus is an aspect that has over time 
attracted the interest of different researchers. In the middle of the 20th century, Hannay conducted 
observations on fixed and embedded sporulating cells and spores under light and electron microscopy, 
????????????????????????????????????????-shaped parasporal body is formed before the completion of 
???????????? ???? ????????? ?????? ????????? ??? ???? ?????? ?????? ???????????? because it ??? ?part of  
?????????? [31].  
Different hypotheses have been made on the possible roles and functions of these bodies that could 
act as storage units if spores germinate in deficient media, might assist spore germination or might be 
an accessory wall or just a deformation of the spore wall. However, a specific function has not been 
confirmed so far. Fitz James and Young (1958) analyzed the chemical composition of the  
canoe-spore-coat structure, after developing a method for its separation from the spore protoplast [32]. 
According to their study, the main components of the CSPB are phosphorous and nitrogen. In addition 
to abundant phosphates, proteinaceous material was recovered through alkaline extraction in the 
presence of reducing agents (alkali-thioglicollate) disrupting S-S bonds. The results of combined 
morphological and chemical analyses suggest that the phosphorus component is part of a lamellar 
structure while extractable proteins would correspond to the matrix of the ?canoe?. 
Other parasporal bodies (PBs), distinct from the CSPB, were noted inside the sporangium by 
Montaldi and Roth (1990) who identified a second type, globular to angular in shape, and a third type, 
striated with alternating parallel bands [33]. The possible function of these structures was not provided, 




but later on the role of B. laterosporus parasporal bodies with variable size and shapes in the 
entomocidal activity against Diptera emerged. 
3. Pathogenicity for Invertebrates  
The pathogenicity of various Brevibacillus laterosporus strains has been confirmed for different 
invertebrates like insects, nematodes and mollusks [21]. Depending on the target, the toxic effects have 
been observed after contact or ingestion of diverse fractions produced at different stages in the 
bacterial growth cycle, from the vegetative to the sporulation phase. Specific protein toxins have been 
identified and their mode of action has been explored. However, many aspects still need to be clarified 
and further investigation is needed.  
3.1. Insects 
3.1.1. Coleoptera 
Different strains of B. laterosporus were employed in experiments with various species of 
Coleoptera. Initially, certain strains were found to be toxic to larvae of the coleopteran species 
Leptinotarsa decemlineata (Say) (Coleoptera: Chrysomelidae) and Lasioderma serricorne (Fabricius) 
(Coleoptera: Anobiidae) [34,35]. 
Similarly, some isolates were found to be toxic to the red palm weevil Rhynchophorus ferrugineus 
(Olivier) (Coleoptera: Curculionidae) [36] and the boll weevil Anthonomus grandis Boheman 
(Coleoptera: Curculionidae) [1]. Slight toxicity was observed under laboratory conditions by topical 
applications of a bacterial mixture including B. laterosporus against adults of the snout-beetle 
Gonipterus scutellatus Gyllenhal (Coleoptera: Curculiionidae), a defoliator of Eucalyptus plantations [37]. 
A B. laterosporus isolate was also recorded to be highly toxic in comparative bioassays with 
different Bacillus thuringiensis Berliner isolates against Tenebrio molitor L. (Coleoptera: Tenebrionidae) 
larvae. An LC50 value of 3.388 × 106 spores/mL was determined [38].  
The molecular characterization of certain coleopteran-active strains demonstrated the production of 
insecticidal protein toxins showing similarity to those produced by B. thuringiensis. These toxins are 
secreted and released in the culture broth and consequently toxicity is associated with the culture 
supernatant, which is particularly active against Diabrotricine beetles also known as corn rootworms 
(Diabrotrica spp.). ?????? ?????????????? ????????? ?????????? ?ISPs) are also toxic to other coleopteran 
species such as Leptinotarsa spp. and Anthonomus spp., but they do not show any toxicity against 
Lepidoptera. The protein nature of these toxins was at first determined by the observation that 
supernatant heat treatments caused a loss of toxicity, whereas retention of activity was observed after 
ammonium sulfate precipitation. Novel ISPs were designated as ISP1A and ISP2A and the DNA 
sequences encoding them was determined [39]. Interestingly, a primary ISP protein is toxic only if 
ingested by the insect in combination with its complementary ISP protein, and no significant toxicity is 
observed when an ISP protein is used in isolation. ISP1A and ISP2A have molecular weights  
of 95?100 kDa and 45?50 kDa, respectively, as determined by standard 8%?10% SDS-PAGE, and 
show high homology with B. thuringiensis vegetative insecticidal proteins (VIP), so that they are now 
listed as Vip1Da1 and Vip2Ad1, respectively [40,41]. Other vegetative insecticidal proteins with a 




molecular weight of about 80 kDa and 40 kDa have been discovered and named MIS (=Vip1Ba1) and 
WAR (=Vip2Ba1), respectively [42]. Their genes were cloned and expressed in B. thuringiensis as 
well as inserted into plants using Agrobacterium tumefaciens (Smith and Townsend) Conn as 
transformation agent. These toxins are also highly toxic to larvae of Diabrotica spp.. 
3.1.2. Lepidoptera 
The results of B. laterosporus bioassays against Lepidoptera are controversial as a consequence of a 
considerable variability among different isolates. B. laterosporus strains show variable toxicity levels 
to the velvetbean caterpillar Anticarsia gemmatalis Hubner (Lepidoptera: Noctuidae), while the same 
strains were not toxic to the fall armyworm Spodoptera frugiperda (J.E. Smith) (Lepidoptera: 
Noctuidae) [1]. Moreover, some strains toxic against mosquitoes failed to show significant pathogenicity 
against larvae of the tobacco budworm Heliothis virescens F. (Lepidoptera: Noctuidae), the cabbage 
looper Trichoplusia ni Hubner (Lepidoptera: Noctuidae), the european corn borer Ostrinia nubilalis 
Hubner (Lepidoptera: Pyralidae), and the tobacco hornworm Manduca sexta (Linnaeus) (Lepidoptera: 
Sphingidae) [34,43]. 
B. laterosporus was isolated from larvae of the codling moth Cydia pomonella L. (Lepidoptera: 
Tortricidae), collected from leaves of apple trees in Turkey [44]. Remarkably, among other bacterial 
species isolated from the same sites, it exhibited the most toxicity.  
3.1.3. Mosquitoes and Black Flies 
The earliest reports on the insecticidal potential of B. laterosporus involved studies with 
mosquitoes. The pathogenicity of 29 strains against Culex quinquefasciatus Say (Diptera: Culicidae) 
and Aedes aegypti (L.) (Diptera: Culicidae) larvae and for the black fly Simulium vittatum Zetterstedt 
(Diptera: Simuliidae) was demonstrated by Favret and Yousten [43], although the level of toxicity 
recorded was about 1,000 times less than the mosquitocidal strain of B. thuringiensis serovar 
israelensis H14. Unlike the previously described cases of Coleoptera, the pathogenicity for mosquitoes 
was not associated to the culture supernatant, but to the cell mass and the effects were maintained after 
bacteria were killed by UV irradiation, which supported the hypothesis of a toxin mediated process. 
Toxicity was associated with stationary-phase cells or to sporulated cultures, as confirmed by 
subsequent studies [34]. In line with this, a recent study with B. laterosporus indicated that spores with 
their CSPB structures were the main location of toxins active against A. aegypti [45]. 
Following the discovery of B. laterosporus Strains 615 and 921 from Russia, the production of 
cytoplasmic crystalline inclusions of various shapes and sizes [46] and their roles in insecticidal 
activity against mosquitoes were reported [47]. In this case, the insecticidal action was also 
immediately associated with sporulated cells rather than the culture supernatant. An overproduction of 
crystalline inclusions was obtained by growing B. laterosporus on Nickerson agar instead of Nickerson 
broth. Crystalline inclusions were purified from spores, their protein concentration determined and 
their insecticidal activity confirmed against A. aegypti and Anopheles stephensi Liston  
(Diptera: Culicidae). The observed median lethal concentration (LC50) was 3.0 ng mL?1 and 5 ng mL?1, 
respectively. These levels of toxicity are comparable to those known for the highly toxic mosquitocidal 
strains of B. thuringiensis subsp. israelensis [48]. Major proteins with a molecular weight of 68 kDa and 




130 kDa were identified in the crystal fractions from these B. laterosporus strains [49]. In a recent 
study, a mosquitocidal activity was found in crystal-forming strains of B. laterosporus after 
incapsulation of spores and crystal mixtures in the protozoa Tetrahymena pyriformis GL and 
Entamoeba moshkovskii Chalaia. Interestingly, the spore-crystal preparations were not toxic to 
protozoa cells [50]. 
3.1.4. House Fly 
First evidence of the susceptibility of the house fly Musca domestica L. (Diptera: Muscidae) to 
B. laterosporus was reported in 2006 by Ruiu et al. [51], who employed sporulated cultures of the 
bacterium. The observed signs and symptoms of B. laterosporus infection on the house fly are similar 
to those caused by other entomopathogenic bacteria, such as B. thuringiensis, on various insect 
targets [52]. In addition to lethal effects on adults and larvae exposed to a treated diet, the effects of 
sub-lethal concentrations were studied. These included a significant increase in larval development 
time and reductions in pupal weight, emergence rate, adult fecundity and longevity. More detailed 
studies on the effects of different bacterial fractions on house flies, corroborated the results of Favret 
and Yousten [43], who reported that vegetative cells become toxic to mosquitoes in the stationary 
phase, and that toxicity increases and is maintained after sporulation [45]. In the case of house flies, 
spores of the toxic strain were identified as the main source of toxicity. A nearly pure fraction of 
spore-coats attached to the CSPBs, obtained through protoplast disruption with glass beads, showed 
toxicity against flies, and a protein fraction they contain was directly associated to the insecticidal 
effects. Carrying toxins attached firmly to the viable spore can be seen as an advanced strategy of a 
bacterium like B. laterosporus in comparison to other bacteria like B. thuringiensis whose full 
insecticidal action relies on the adventitious co-ingestion of spores and free cytoplasmic toxin crystals. 
Observations on insect behavior and midgut ultrastructure after ingestion of B. laterosporus spores 
have been conducted to study the subsequent pathological and histopathological events [53]. For this 
purpose, larvae were dissected at different time intervals after treatment and the mid-midgut portion 
dissected and fixed for tissue analysis under transmission electron microscopy (TEM). In comparison 
to healthy insects, treated ones rapidly reduced their feeding and growth rate, becoming sluggish 
before paralysis and death. At the same time, the midgut epithelium deteriorated and showed 
progressively more dramatic alterations including endoplasmic reticulum deformation, mitochondria 
alteration, microvilli disruption, cytoplasm vacuolization and general disorganization with cell lysis. 
Degenerative changes also affected the midgut muscular sheath and connective tissue, thus suggesting 
a correlation with a behavioral symptomatology, ending with insect paralysis. Remarkably, affected 
and unaffected midgut epithelial cells were often adjacent to one another, which suggests a 
cell-specific susceptibility related to the interaction of bacterial toxins with the epithelial cell 
membranes. Similar cellular alterations were observed on fly adults [54]. 
Experimental formulations based on B. laterosporus spores have been developed and employed in 
application trials on house fly breeding sites in dairy farms, where a significant suppression of adult 
emergence from manure was obtained [55,56].  
Another worthy aspect that has been investigated in the evaluation of B. laterosporus as a biological 
control agent against flies, is its safety towards non-target species, with special regard to the 




hymenopteran house fly pupal parasitod Muscidifurax raptor Girault and Sanders  
(Hymenoptera: Pteromalidae) [57] and to the honey bee Apis mellifera L. (Hymenoptera: Apidae) [58]. 
3.2. Nematodes 
B. laterosporus was found to be a biocontrol agent of parasitic nematodes after a nematicidal 
compound from spores of certain strains was discovered to inhibit egg hatching and larval 
development of roundworms. The toxin, isolated by HPLC, was a heat stable, low molecular weight 
protein of approximately 2,900 daltons, characterized by UV absorbance at 205, 220 and 268 nm [59]. 
Nematicidal activity was reported for parasitic nematodes of animals (i.e., Trichostrongylus 
colubriformis (Giles)) and of plants (i.e., Heterodera glycines Ichinohe) [35]. 
The role of extracellular proteases produced by B. laterosporus strain G4 in toxicity to nematodes 
has been confirmed [60]. The alkaline protease BLG4 was purified from the culture supernatant of the 
bacterium and assayed against the free-living nematodes Panagrellus redivivus Goodey and the plant 
parasite nematode Bursaphelenchus xylophilus (Steiner and Buhrer) Nickle. As observed under 
scanning electron microscopy, these proteins caused severe damage to the nematode cuticle, with 
exfoliation of outer layers and the creation of many flaws and scars. The observed effects are 
reminiscent of those caused by nematophagous fungi whose penetration into nematode body is 
associated with the action of extracellular proteases that degrade the outer proteinaceus cuticle 
membrane and the matrix connecting chitin miofibrils to the cuticle of the nematode [61]. This mode 
of action implying a major role of cuticle degrading proteases, is shared by a community of 
rhizobacterial species exhibiting nematicidal activity, including B. laterosporus [62]. The activity of 
BLG4 against nematodes was also demonstrated by in vitro bioassays employing purified 
recombinants. The BLG4 enconding gene was cloned and expressed in Bacillus subtilis (Ehrenberg) 
Cohn and the gene analysis revealed that it showed a high homology with genes encoding for the 
subtilisin family of serine proteases and for other cuticle-degrading proteases. A significant reduction 
in pathogenicity was obtained in bioassays employing a BLG4-deficient mutant [63]. The involvement 
of the protease in the bacterial infection process was also demonstrated by its immunofluorescent 
localization during the degradation of nematode cuticles [64,65]. Although purified proteases were 
identified as major toxic factors, they were able to cause mortality of nematodes less than the crude 
extracellular extract, so other virulent factors are implicated [66]. 
3.3. Mollusks 
The molluscicidal activity of bacterial strains belonging to the Brevibacillus brevis phylogenetic 
cluster, including B. laterosporus, was initially reported against the aquatic snail Biomphalaria 
glabrata (Say), an important vector of flatworm parasites of the genus Schistosoma, etiologic agents of 
the tropical disease schistosomiasis [67]. In the target range include the zebra mussel Dreissena 
polymorpha (Pallas), an invasive bivalve species with severe negative impacts on aquatic ecosystems, 
with special regard to phytoplankton, zooplankton, vegetation, water chemistry, zoobenthos and 
fish [68]. The toxicity against mollusks is associated with the whole bacterial culture, and has been 
specifically associated to the production of bacterial antibiotics such as Gramicidin S and D [69].  
A higher susceptibility was observed for animals with a shorter life cycle, and the levels of toxicity 




against the zebra mussel veliger stage were comparable to that of the entomopathogen B. thuringiensis 
against its targets.  
4. Antimicrobial Features 
Some B. laterosporus strains exhibit a broad-spectrum antimicrobial activity against various 
bacteria and fungi. This biological property is shared with members of the Brevibacillus clade and has 
been associated with the production of a wide range of enzymes and antibiotics [70]. 
Growth inhibition of the phytopathogenic fungi Fusarium oxysporum f. sp. ciceri (Padwick) Matuo 
& K. Sato, F. semitectum Berk. and Ravenel, Magnaporthe grisea (Hebert) Barr and Rhizoctonia 
oryzae Ryker and Gooch, and of the Gram-positive coccal bacterium Staphylococcus aureus 
Rosenbach was caused by a B. laterosporus strain, designated BPM3, isolated from mud in India. The 
antibacterial and antifungal compounds responsible for the observed effects were purified and 
characterized. Preliminary information on the chemical composition of the most active fraction was 
obtained by spectroscopic analysis indicating the presence of C-H, the carbonyl group, the dimethyl 
group, -CH2 and the methyl group [71]. 
Evidence of fungal inhibition was obtained with the B. laterosporus isolate ZQ2 against various 
apple tree phytopathogens including Rhizoctonia solani Kuhn, Fusarium oxysporum Schlecht, 
F. solani (Mart.), Aspergillus fumigatus Fres, Alternaria alternata (Fr.) Keissler, Valsa sordida Nits, 
Colletotrichum gloeosporioides (Penz.) Penz. and Sacc., Botrytis cinerea Pers. and Physalospora 
piricola Nose. This strain was isolated from an apple tree rhizosphere in China. The antifungal activity 
of the culture filtrate, achieving an inhibition level of around 80%, was maintained after heat 
treatments up to 120 °C for 30 min, ultraviolet irradiations or pH variations from 1 to 11 [72]. 
B. laterosporus has long been noted for its antifungal properties when isolated from rhizosphere soil 
samples [73] and features among plant growth promoting rhizobacteria (PGPR) [74]. In specific 
experiments, B. laterosporus preparations promoted lettuce seedling growth [75].  
These properties have been associated with the production of antimicrobial peptides, and an agar 
diffusion bioassay for their bioactivity quantification has been developed [76]. More recently, a novel 
antimicrobial peptide with a molecular mass of about 1,600 Da from B. laterosporus strain A60 was 
isolated and characterized [77]. This short sequence liner peptide, designated BL-A60, was isolated 
from the culture broth and its inhibitory activity was determined against diverse plant pathogens 
including the Gram negative bacteria, Pseudomonas solanacearum (Smith) Smith and Xanthomonas 
campestris pv. vesicatoria (Doidge) Dye, the Gram-positive bacterium, Bacillus subtilis (Ehrenberg) 
Cohn, and the fungi, Phytophthora capsici Leonian, B. cinerea, Verticillium dahliae Kleb, 
F. oxysporum. The antimicrobial activity was thermostable, being maintained at 100 °C for 15 min 
after treatment, and was not affected by pH variations from 3 to 11, or after treatments with protease k, 
trypsin and pepsin. Among the chemical properties is the fact that it is a cationic peptide, soluble either 
in water or in organic solvents (e.g., acetonitrile), which indicates an amphipathic behavior. 
It is debated that the action of antimicrobial peptides against their microbial targets implies the 
interaction with the cell membrane where the formation of ion channels and transmembrane pores 
leads to cell rupture and lysis. Eventually, peptides might enter the cell and be translocated in the 




cytoplasm where they can disturb protein synthesis by interacting with DNA and RNA [78]. The 
BL-A60 might act in a similar way, but these aspects have not been clarified so far. 
Some strains of B. laterosporus also produce chitinases that may play a major role in the 
degradation of the cell wall of fungi. A new B. laterosporus isolate from mangrove marsh soil in India, 
designated Lak1210, when grown on media containing colloidal chitin, produces chitinases that are 
released in the culture supernatant. The activity of these antifungal proteins was assayed against the 
phytopathogenic fungus Fusarium equiseti (Corda) Sacc. These proteins show high homology with 
a 89.4-kDa four domain chitodextrinase and with a 69.4-kDa two domain chitinase (ChiA1) encoded 
by B. laterosporus LMG15441 [79]. Another recently discovered broad-spectrum antimicrobial peptide 
produced by strain GI-9 is laterosporulin, a thermo-stable peptide with a molecular mass of 5.6 kDa [80]. 
Besides phytopathogenic bacteria and fungi, the antimicrobial properties of B. laterosporus were 
also demonstrated in vitro against the bacterium Paenibacillus larvae (White), the causal agent of 
American foulbrood of honeybees [81]. 
The antifungal and antibacterial properties of certain B. laterosporus strains have found interest in 
medicine for their production of antibiotics with therapeutic effects. An example is represented by the 
antibiotic laterosporamine that shows in vitro and in vivo inhibitory effects against a broad spectrum of 
Gram-positive and Gram-negative bacteria including B. subtilis, Bacillus anthracis Cohn, Staphylococcus 
aureus Rosenbach, Streptococcus pneumoniae (Klein) Chester, Streptococcus pyogenes Rosenbach, 
Escherichia coli (Migula) Castellani and Chalmers, Klebsiella pneumoniae (Schroeter) Trevisan, 
Salmonella typhimurium (Loeffler) Castellani and Chalmers, Pseudomonas aeruginosa  
(Schroeter) Migula [82]. 
A B. laterosporus strain isolated from tropical sea water at the Papua New Guinea coast was found 
to produce in culture the acyldipeptides tupuseleiamides and the antifungal polyketides basiliskamides, 
which significantly inhibited the bacterium E. coli and the fungus Candida albicans (Robin) 
Berkhout [83]. The same marine isolate (PBG-276) was reported to produce various antibiotics 
including loloatins, bogorols and the lipopeptide tauramamide [84].  
Among other antibiotics released in the culture broth by B. laterosporus are the cyclodecapeptide 
laterocidin [85], the thrombin inhibitors bacithrocins A, B and C [86], the aminopeptidase M inhibitor 
leuhistin [87] and the antitumor antibiotic spergualin [30]. Other strains produce the industrially 
important enzyme cephalosporin acylase, useful in the cephalosporin derivatives production process. 
The strains were isolated from soil [88]. 
Owing to the antagonism against various noxious microorganisms, B. laterosporus is reported to 
produce beneficial effects also inside mammalian intestines after being administered as a feed 
additive [28]. As a result of these probiotic effects, the oral administration of B. laterosporus spores to 
poultry can improve feed conversion and weight gain [29,89]. 
5. Other Properties and Uses 
Due to the production of various metabolites, B. laterosporus bioactivity is not limited to 
invertebrates, bacteria and fungi. Among other possible applications, algicidal effects against the 
harmful cyanophytes belonging to different genera including Oscillatoria, Anabaena, Microcystis and 
Nostoc, have been demonstrated [90,91].  




Another field of growing interest is the use of microorganisms for bioremediation that is the 
biotreatment of a contaminated site for the degradation and removal of pollutant or contaminant 
compounds. The list of substances that can be degraded by B. laterosporus strains is continuously 
growing. Representative examples are the biodegradation of polyvinyl alcohol to acetate [92], the 
decolorization of different textile azo dyes through the production of diverse enzymes including lignin 
peroxidase, laccase, aminopyrine N-demethylase, NADH-DCIP reductase and malachite green 
reductase [93], the biodegradation of vegetable tannins in tannery effluents [94], the biodegradation of 
toluene and phenol [95], the biosorption of toxic metals from aqueous solutions [96] and metal 
detoxification in wastewater systems [97,98]. 
6. Conclusions  
Wide-ranging studies have emphasized the potential of B. laterosporus as a biological control agent 
against insects, nematodes, mollusks and plant pathogens. In addition, owing to its antimicrobial 
features and to the production of specific antibiotic compounds, this species have found use in 
medicine. More recently, as a result of its biodegradation and decontamination properties, its use in 
bioremediation has also been proposed (Table 1). 
Table 1. Summary of the range of activity of Bravibacillus laterosporus and some of the 
active compounds produced by different isolates.  
Active compounds Main activity References 
Complementary toxins ISP1 and ISP2 
(=Vip1Da1; Vip2Ad1) 
Insecticidal (Coleoptera) [40,41] 
Complementary toxins MIS and RAR 
(=Vip1Ba1 and Vip2Ba1) 
Insecticidal (Coleoptera) [42] 
Insecticidal crystal proteins (PBs) Mosquitocidal [49] 
Proteins from spores and CSPB Insecticidal (mosquitoes, flies) [34,43,45] 
Low MW (2,900 Da) protein Nematicidal [59] 
Alkaline protease BLG4 Nematicidal [60?65] 
Chitinases (i.e., ChiA1, chitodextrinase) Insecticidal, fungicidal [79] 
Gramicidin S and D Molluscicidal [69] 
Diverse antimicrobial compounds Antibacterial, antifungal [71,72] 
BL-A60 Antimicrobial peptide Antibacterial, antifungal [77] 
Laterosporulin Antibacterial [80] 
Antibiotics and drugs 
(i.e., laterosporamine, tupuseleiamides, 
basilikamides, loloatins, bogorols, taraumide, 
laterocidin, bacithrocins A-B-C, leuhistin, 
spergualin, cephalosporin acylase) 




(i.e., lignin peroxidase, laccase, aminopyrine 
N-demethylase, NADH-DCIP reductase and 








After the first diversity studies conducted to compare the genomes of different B. laterosporus 
strains [99], more recently the whole genome sequencing of strains LMG 15441 and GI-9 generated 
valuable information on the genomic determinants of the useful activities of this bacterium [26,27]. 
The potential to produce a variety of polyketides and nonribosomial peptides was highlighted, 
corroborating the results of studies on its antimicrobial and antibiotic features. In addition, different 
putative genes encoding potential virulence factors were detected. Among these, there are genes 
encoding collagenase, chitinases, immune inhibitors, and insecticidal toxins showing similarities to 
other bacterial biocides, as produced by Lysinibacillus sphaericus Meyer and Neide.  
Interestingly, despite a high genotypic homology among strains, differences in phenotypic 
properties have been detected, which is in line with a variable activity range expressed by different 
strains. Decades of studies with the best-established insect pathogen, B. thuringiensis, have uncovered 
a wide diversity of insecticidal toxins being synthesized by diverse strains. Similarly, new 
B. laterosporus isolates are continuously being collected worldwide and efforts are being conducted  
to purify and characterize novel bacterial enzymes and compounds for biotechnological  
exploitation [77,79,80,100,101]. However, the mechanism of action of many compounds is still 
undetermined and further investigation is needed. Future screening studies will also reveal other 
possible and useful applications of this multifunctional species. 
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